Back
Tango Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
TNGX
Sponsored
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm
Sell
50
TNGX
Tango Therapeutics
Last Price:
8.42
Seasonality Move:
27.24%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Tango Therapeutics Price Quote
$8.42
+0.14 (+1.69%)
(Updated: September 19, 2024 at 6:55 PM ET)
Tango Therapeutics Key Stats
Sell
50
Tango Therapeutics (TNGX)
is a Sell
Day range:
$8.27 - $8.98
52-week range:
$5.15 - $13.03
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
20.36
P/B ratio:
3.58%
Volume:
1.1M
Avg. volume:
961.1K
1-year change:
-8.1%
Market cap:
$887.2M
Revenue:
$36.5M
EPS:
$-1.12
How Much Does Tango Therapeutics Make?
-
How Much Are Tango Therapeutics's Sales Annually?
TNGX Revenues are $36.5M -
How Much Profit Does Tango Therapeutics's Make A Year?
TNGX net income is -$101.7M
Is Tango Therapeutics Growing As A Company?
-
What Is Tango Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.36% -
What Is Tango Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Tango Therapeutics Stock Price Performance
-
Did Tango Therapeutics Stock Go Up Last Month?
Tango Therapeutics share price went down by -16.87% last month -
Did TNGX's Share Price Rise Over The Last Year?
TNGX share price fell by -8.1% over the past 1 year
What Is Tango Therapeutics 52-Week High & Low?
-
What Is Tango Therapeutics’s 52-Week High Share Price?
Tango Therapeutics has traded as high as $13.03 over the past 52 weeks -
What Is Tango Therapeutics’s 52-Week Low Share Price?
Tango Therapeutics has traded as low as $5.15 over the past 52 weeks
Tango Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Tango Therapeutics?
-
How Much Debt Does Tango Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Tango Therapeutics Have?
Cash and short term investments quarterly total is $322.1M -
What Is Tango Therapeutics’s Book Value Per Share?
Book value per share is 2.31
Is Tango Therapeutics Cash Flow Positive?
-
What Is TNGX Cash Flow From Operations?
Cash flow from operations (TTM) is -$120.1M -
What Is Tango Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $126M -
What Is Tango Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$21.3M
Tango Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
TNGX return on invested capital is -46.42% -
What Is Tango Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -29.16% -
What Is TNGX Return On Equity?
ROE is a measure of profitability and is -46.42%
Tango Therapeutics Earnings Date & Stock Price
-
What Is Tango Therapeutics's Stock Price Today?
A single share of TNGX can be purchased today for 8.28 -
What Is Tango Therapeutics’s Stock Symbol?
Tango Therapeutics trades on the nasdaq under the ticker symbol: TNGX -
When Is Tango Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Tango Therapeutics is scheduled on November 8, 2024 -
When Is TNGX's next ex-dividend date?
Tango Therapeutics's next ex-dividend date is September 20, 2024 -
How To Buy Tango Therapeutics Stock?
You can buy Tango Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Tango Therapeutics Competitors
-
Who Are Tango Therapeutics's Competitors?
Below is a list of companies who compete with Tango Therapeutics or are related in some way:
Tango Therapeutics Dividend Yield
-
What Is TNGX Dividend Yield?
Tango Therapeutics’s dividend yield currently is 0% -
What Is Tango Therapeutics’s Payout Ratio?
Tango Therapeutics’s payout ratio is 0% -
When Did Tango Therapeutics Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is Tango Therapeutics’s Dividend Per Share?
Tango Therapeutics pays a dividend of $0.00 per share
Tango Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 31.67% |
Revenue: | 36.15% | 160.42% |
Analyst Recommendations
Buy Recommendations: | 6 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 16.13 |
Upside from Last Price: | 94.75% |